Bradley C J, French M T, Rachal J V
Research Triangle Institute, Research Triangle Park, North Carolina.
J Subst Abuse Treat. 1994 Sep-Oct;11(5):433-42. doi: 10.1016/0740-5472(94)90096-5.
Although some national surveys of drug-abuse treatment have examined cost and financing issues, our study is one of the first to rigorously analyze the costs and financing of methadone treatment at the program level. Our findings are similar to those found at the national level for treatment cost but deviate significantly from the National Drug and Alcoholism Treatment Unit Survey (NDATUS) findings on funding sources. In addition to examining financing and total cost, we grouped resources into particular categories and examined variations at the client, program, regimen, and setting levels. Our specific findings show that public funding sources overwhelmingly support the programs examined; the average annual cost per client for standard methadone treatment was between $3,750 and $4,400; the marginal cost of providing enhanced treatment was between 5% and 6% of the total annual cost of standard treatment; and the average annual cost at the freestanding community-based programs was significantly different from the average annual cost at the hospital-based treatment program. Our results provide a treatment cost methodology along with a financial profile of treatment operations at three clinics that can be compared across programs and settings.
尽管一些全国性药物滥用治疗调查研究了成本和融资问题，但我们的研究是首批在项目层面严格分析美沙酮治疗成本和融资情况的研究之一。我们的研究结果在治疗成本方面与全国层面的结果相似，但在资金来源方面与全国药物和酒精中毒治疗单位调查（NDATUS）的结果有显著差异。除了研究融资和总成本外，我们还将资源分为特定类别，并研究了客户、项目、治疗方案和治疗场所层面的差异。我们的具体研究结果表明，公共资金来源在很大程度上支持了所研究的项目；标准美沙酮治疗每位客户的年均成本在3750美元至4400美元之间；提供强化治疗的边际成本占标准治疗年度总成本的5%至6%；独立社区项目的年均成本与医院治疗项目的年均成本有显著差异。我们的研究结果提供了一种治疗成本方法以及三家诊所治疗运营的财务概况，可在不同项目和场所之间进行比较。
